Amgen Kineret indication
Executive Summary
Kineret is indicated "for the reduction in signs and symptoms of moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed one or more disease modifying antirheumatic drugs (DMARDs). Kineret can be used alone or in combination with DMARDs other than tumor necrosis factor (TNF) blocking agents." ("The Pink Sheet", Nov. 19, p. 3), incorrectly reported the indication...